Mydecine Innovations Group Sponsors First Lab-Based Study of Established Microdosers at Macquarie University in Australia Post published:January 5, 2021 Post category:Press Release
MindMed Files Final Prospectus In Connection With Bought Deal Equity Financing Post published:January 4, 2021 Post category:Press Release
Empower Clinics Closes Agreement to Acquire Canadian Clinics, Announces Significant Discussions with Nationwide Rollout Partners and Proceeds From Exercise of Warrants Now Exceeding $6,900,000 to Conclude its Most Successful Year Ever Post published:January 4, 2021 Post category:Press Release
NeonMind Commences Trading Under CSE Ticker Symbol “NEON” Post published:January 4, 2021 Post category:Press Release
BetterLife Files Patent for the Treatment of MDD Utilizing its Second-Generation Psychedelic Derivative for 2-Bromo-LSD Post published:January 4, 2021 Post category:Press Release
Ehave, Inc. Files to List on the Canadian Stock Exchange and Applies to Upgrade to OTCQB Exchange Post published:January 4, 2021 Post category:Press Release
Entheon Biomedical Announces Investment and Business Arrangement with Heading Health LLC Post published:January 4, 2021 Post category:Press Release
Nova Mentis Appoints Dr. Kyle Ambert to Scientific Advisory Board Post published:January 4, 2021 Post category:Press Release
Red Light Holland Engages Graham Pechenik, Respected Patent and IP Lawyer and Editor-at-Large of Psilocybin Alpha, as Senior Advisor to Advisory Board Post published:December 31, 2020 Post category:Press Release